Vaxcyte Inc. (NASDAQ:PCVX) is one of the 13 hot stocks to buy with the highest upside potential. On February 2, Vaxcyte Inc. (NASDAQ:PCVX) closed its public offering of the sale of 12.65 million shares of the company’s common stock at $50 per share, raising $632.5 million in gross proceeds in the process. The offering included the full exercise of the underwriters’ option to purchase an additional 1.65 million shares at the public offering price, less underwriting discounts and commissions. Meanwhile, on ...

Nebius Group NV (NASDAQ:NBIS) is one of the 13 hot stocks to buy with the highest upside potential. On February 9, analyst Josh Baer from Morgan Stanley maintained a Hold rating on Nebius Group NV (NASDAQ:NBIS), with a price target of $126. The analyst is bullish on the company’s lower total cost of ownership driven by custom infrastructure, its strong software capabilities backed by an experienced developer base, and a diversified customer mix that includes large, investment‑grade clients and strategic equ ...

Amicus Therapeutics Inc. (NASDAQ:FOLD) is one of the 13 hot stocks to buy with the highest upside potential. On January 27, TD Cowen analyst Ritu Baral maintained the firm’s Hold rating on Amicus Therapeutics Inc. (NASDAQ:FOLD), as well as the $14.50 price target on the stock. Amicus’s pre-announced fourth-quarter and full-year 2025 total product revenue were modestly above expectations, according to TD Cowen, with Fabry disease medication Galafold delivering a clear outperformance versus consensus estimate ...

ImmunityBio Inc. (NASDAQ:IBRX) is one of the 13 hot stocks to buy with the highest upside potential. On February 2, ImmunityBio Inc. (NASDAQ:IBRX) announced that it has initiated a Phase 2 clinical trial evaluating a novel combination immunotherapy for patients with indolent B-cell non-Hodgkin lymphoma (iNHL). Meanwhile, on January 26, ImmunityBio Inc. (NASDAQ:IBRX) amended a $505 million convertible promissory note with Nant Capital LLC, allowing the noteholder to convert any portion of the outstanding p ...

Ondas Inc. (NASDAQ:ONDS) is one of the 13 hot stocks to buy with the highest upside potential. On February 9, Ondas Inc. (NASDAQ:ONDS) announced that its subsidiary 4M Defense has secured a multi-year demining contract in Israel valued at more than $30 million. The contract, which has an initial execution period of up to three years, covers about 741 acres along the Israel-Syria border and is described as one of the largest land-clearance initiatives ever undertaken in Israel. Meanwhile, on February 4, JC ...

Casey also emphasized that the enterprise is now Amplitude’s “core growth engine,” citing 20% year-over-year ARR growth for the enterprise customer cohort, along with higher retention and expansion rates than the rest of the business. Remaining performance obligations (RPO) were another focus: Casey said Amplitude sustained current RPO growth of more than 20% throughout 2025, and total RPO grew 35% year over year in Q4, with average contract duration now above 22 months .On profitability, CFO Andrew Casey s ...

Alford said trailing 12-month active buyers were roughly 135 million in Q4; excluding buyers from the recently acquired Tise, active buyers were over 134 million, up nearly 1% year-over-year organically. Enthusiast buyers were stable at about 16 million, while spend per enthusiast buyer increased to over $3,300 on a trailing 12-month basis.For the fourth quarter, CFO Peggy Alford reported GMV growth of over 8% to $21.2 billion and revenue growth of over 13% to $2.96 billion, both on an organic, FX-neutral b ...

CFO Ravi Inukonda said his expectations for full-year 2026 EBITDA have not changed since the prior call. He said DoorDash expects 2026 EBITDA margin to be “up slightly compared to 2025, excluding Deliveroo,” and reiterated that Deliveroo is expected to produce about $200 million of EBITDA for the year.More broadly, Xu said the company’s business outside the U.S. is growing faster than in the U.S.—which he noted had “two of the fastest-growing quarters in 2025 in the last four years”—and that DoorDash is con ...

Wave Life Sciences Ltd. (NASDAQ:WVE) is one of the 13 hot stocks to buy with the highest upside potential. On February 5, BofA initiated coverage of Wave Life Sciences Ltd. (NASDAQ:WVE) with a Buy rating and $38 price target. The analyst expects the company’s obesity medication, WVE-007, to become a key value driver, accounting for 56% of the firm’s price target and peaking at greater than $11 billion in sales, likely beating Wall Street estimates. Meanwhile, on February 3, Canaccord Genuity raised its pr ...

Dyne Therapeutics Inc. (NASDAQ:DYN) is one of the 13 hot stocks to buy with the highest upside potential. As of February 13, nearly 90% of analysts who cover the stock have assigned a Buy or equivalent rating. The consensus 1-year median price target of $39.5 implies a 138% upside. Earlier, on January 21, Francois Brisebois from LifeSci Capital reiterated a Buy rating on Dyne Therapeutics Inc. (NASDAQ:DYN), with a price target of $44. Meanwhile, on January 20, Dyne Therapeutics Inc. (NASDAQ:DYN) announce ...